Molecular Detection of Helicobacter pylori and its Antimicrobial Resistance in Brazzaville, Congo

Ontsira Ngoyi EN 1 , Atipo Ibara BI 2 , Moyen R 3 , Ahoui Apendi PC 2 , Ibara JR 2 , Obengui O 1 Show all authors , Ossibi Ibara RB 2 , Nguimbi E 3 , Niama RF 3 , Ouamba JM 4 , Yala F 1 , Abena AA 5 , Vadivelu J 6 , Goh KL 6 , Menard A 7 , Benejat L 8 , Sifre E 8 , Lehours P 7 , Megraud F 7

Affiliations 

  • 1 Microbiology and Haematology Department, Health Sciences Faculty, Brazzaville, Congo
  • 2 Medicine Department, Health Sciences Faculty, Brazzaville, Congo
  • 3 Molecular and Cellular Biology Department, Technical and Sciences Faculty, Brazzaville, Congo
  • 4 Chemistry plant and life unit, Technical and Sciences Faculty, Brazzaville, Congo
  • 5 Biochemistry Department, Health Sciences Faculty, Brazzaville, Congo
  • 6 University of Malaya, Kuala Lumpur, Malaysia
  • 7 INSERM U853, Bordeaux, France
  • 8 French National Reference Center for Campylobacters and Helicobacters, University of Bordeaux, Bordeaux, France
Helicobacter, 2015 Aug;20(4):316-20.
PMID: 25585658 DOI: 10.1111/hel.12204

Abstract

Helicobacter pylori infection is involved in several gastroduodenal diseases which can be cured by antimicrobial treatment. The aim of this study was to determine the prevalence of H. pylori infection and its bacterial resistance to clarithromycin, fluoroquinolones, and tetracycline in Brazzaville, Congo, by using molecular methods.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications